News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Luciano Costa, MD

Articles by Luciano Costa, MD

Key Takeaways for Early Relapse Multiple Myeloma Management

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

May 13th 2026

Managing Comorbid Patients in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

May 13th 2026

Risk Stratification and Shared Decision-Making in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

May 6th 2026

Sequencing CAR-T and Bispecifics in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

May 6th 2026

Case-Based Sequencing Decisions in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 29th 2026

Positioning Bispecific Therapy in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 29th 2026

Mechanistic Rationale and Combination Strategies in Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 22nd 2026

Managing Toxicities of Bispecific Antibodies in Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 22nd 2026

Safety Considerations for Bispecific Antibodies in Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 15th 2026

Subgroup Insights in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 15th 2026

Interpreting MajesTEC-3 Efficacy in Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 8th 2026

Role of Bispecific Antibodies in Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

April 8th 2026

Unmet Needs in Early Relapse Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

March 31st 2026

Defining Early Relapse and Treatment Selection in Multiple Myeloma

ByLuciano Costa, MD ,Muhamed Baljevic, MD,Carol Ann Huff, MD

March 31st 2026

Latest Updated Articles

Positioning Bispecific Therapy in Early Relapse Multiple Myeloma
April 29th 2026
Case-Based Sequencing Decisions in Early Relapse Multiple Myeloma
April 29th 2026

Trending on CancerNetwork

Teclistamab Induction Shows Feasibility in Transplant-Eligible Myeloma

ASCO Breakthrough 2026 Wrap-Up: Precision Oncology, AI, and Biomarkers Define the Future of Cancer Care

ASCENT-07 and Triple-Negative Breast Cancer Advances

FDA Accepts RP1 BLA Resubmission for Advanced Melanoma

MAIA Long-Term Outcomes in Newly Diagnosed Multiple Myeloma